Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer

During the development of therapeutic microRNAs (miRNAs or miRs), it is essential to define their pharmacological actions. Rather, miRNA research and therapy mainly use miRNA mimics synthesized in vitro. After experimental screening of unique recombinant miRNAs produced in vivo, three lead antiproli...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yixin, Tu, Mei-Juan, Han, Fangwei, Liu, Zhenzhen, Batra, Neelu, Lara, Primo N., Chen, Hong-Wu, Bi, Huichang, Yu, Ai-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547963/
https://www.ncbi.nlm.nih.gov/pubmed/37799388
http://dx.doi.org/10.1016/j.apsb.2023.07.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547963/
https://www.ncbi.nlm.nih.gov/pubmed/37799388
http://dx.doi.org/10.1016/j.apsb.2023.07.011

Ejemplares similares